paxilline has been researched along with Dilatation, Pathologic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, CY; Lin, FY; Lin, YW; Lu, HY; Shih, CC; Shih, CM; Tsai, CS | 1 |
1 other study(ies) available for paxilline and Dilatation, Pathologic
Article | Year |
---|---|
A potential contribution of dipeptidyl peptidase-4 by the mediation of monocyte differentiation in the development and progression of abdominal aortic aneurysms.
Topics: Aged; Aged, 80 and over; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apolipoproteins E; Case-Control Studies; Cell Differentiation; Cell Line, Tumor; Dilatation, Pathologic; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Female; Focal Adhesion Kinase 2; Glucagon-Like Peptide 1; Humans; Macrophages; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Paxillin; RNA Interference; Transfection | 2017 |